モデルナ株価、メラノーマワクチン成功で160%急騰

· businessinsider.com

COVID時代に大成功を収めたモデルナは、次の大型医薬品を模索していた。

After making its name as a vaccine-maker during the COVID era, Moderna has been looking for its second act as a major drug developer. Investors seem to think it...


More AI market news · Market heatmap · StrategyVerse · Quant Research · WOBR.AI